Application Nr Approved Date Route Status External Links
ANDA200502 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Naratriptan Tablets, Usp Are Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. If A Patient Has No Response To The First Migraine Attack Treated With Naratriptan Tablets, Usp Reconsider The Diagnosis Of Migraine Before Naratriptan Tablets, Usp Are Administered To Treat Any Subsequent Attacks. Naratriptan Tablets, Usp Are Not Indicated For The Prevention Of Migraine Attacks. Safety And Effectiveness Of Naratriptan Tablets, Usp Have Not Been Established For Cluster Headache. Naratriptan Tablets, Usp Is A Serotonin (5-Ht 1b/1d ) Receptor Agonist (Triptan) Indicated For The Acute Treatment Of Migraine With Or Without Aura In Adults. (1) Limitations Of Use: Use Only If A Clear Diagnosis Of Migraine Has Been Established. (1) Not Indicated For The Prophylactic Therapy Of Migraine Attacks. (1) Not Indicated For The Treatment Of Cluster Headache. (1)

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Naratriptan Hydrochloride NARATRIPTAN HYDROCHLORIDE ZINC4076

Comments